Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05274997
Title A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Shanghai YingLi Pharmaceutical Co. Ltd.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.